Clinical Trials Browser

Phase 1/2 × Esophageal Squamous Cell Carcinoma × tislelizumab × Clear all

NCT06303583 2024-03-12

CRIS

Phase 1/2 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05394415 2022-05-27

LATE

Phase 1/2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma